Patent ID: 6545056
Filing Date: 2003-04-08
Classification: A61K,A61P

Abstract:
A pharmaceutical composition for the treatment or prophylaxis of inflammatory bowel disease comprising a pharmaceutically acceptable carrier and an effective inflammatory bowel disease-treating amount of a compound selected from the group consisting of:N-cyclohexyl-&agr;-(2-ethoxy4-trifluoromethylphenyl)nitrone, N-(2-methylbut-2-yl)-&agr;-(2-ethoxyphenyl)nitrone, N-tert-butyl-&agr;-{2-[2-(2-chloroethoxy)ethoxy]phenyl}nitrone, N-tert-butyl-&agr;-[2-(methoxycarbonylmethoxy)phenyl]nitrone, N-cyclohexyl-&agr;-(4-ethylphenyl)nitrone, and pharmaceutically acceptable salts thereof.